Antidotes for the new oral anticoagulants: Reality and expectations

被引:0
作者
Gomez-Outes, Antonio [1 ]
Lecumberri, Ramon [2 ]
机构
[1] AEMPS, Div Farmacol & Evaluac Clin, Madrid, Spain
[2] Univ Navarra Clin, Serv Hematol, Pamplona, Navarra, Spain
来源
MEDICINA CLINICA | 2016年 / 146卷 / 11期
关键词
ATRIAL-FIBRILLATION PATIENTS; INTRACRANIAL HEMORRHAGE; DABIGATRAN; MANAGEMENT; IDARUCIZUMAB; WARFARIN; TOLERABILITY; VOLUNTEERS; INHIBITORS; REVERSAL;
D O I
10.1016/j.medcle.2015.11.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:488 / 490
页数:3
相关论文
共 50 条
  • [21] Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?
    Gendron, Nicolas
    Billoir, Paul
    Siguret, Virginie
    Le Cam-Duchez, Veronique
    Proulle, Valerie
    Macchi, Laurent
    Boissier, Elodie
    Mouton, Christine
    De Maistre, Emmanuel
    Gouin-Thibault, Isabelle
    Jourdi, Georges
    THROMBOSIS RESEARCH, 2024, 237 : 171 - 180
  • [22] A review of oral anticoagulants, old and new, in major bleeding and the need for urgent surgery
    Milling, Truman J., Jr.
    Ziebell, Christopher M.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2020, 30 (02) : 86 - 90
  • [23] General characteristics of the new oral anticoagulants
    Gegu, Marine
    Chevalet, Pascal
    Piloquet, Francois-Xavier
    Berrut, Gilles
    De Decker, Laure
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2013, 11 : 4 - 9
  • [24] Perioperative management of new oral anticoagulants
    Samama, Charles-Marc
    Pernod, Gilles
    Albaladejo, Pierre
    Sie, Pierre
    PRESSE MEDICALE, 2014, 43 (06): : 637 - 644
  • [25] Safety assessment of new oral anticoagulants
    Gasso Sanchez, Amalia
    Real Campana, Jose Manuel
    Franco Sorolla, Jose Miguel
    Povar Marco, Bienvenido Javier
    Abad Sazatornil, Maria Reyes
    MEDICINA CLINICA, 2019, 152 (12): : 482 - 487
  • [26] New oral anticoagulants in atrial fibrillation
    Veltkamp, R.
    Hacke, W.
    NERVENARZT, 2011, 82 (02): : 180 - +
  • [27] Importance of the new oral Anticoagulants in Gastroenterology
    Fuchs, E. -S.
    Jakobs, R.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (36) : 1784 - 1786
  • [28] An update on applications and limitations of direct oral anticoagulants
    Wei, Sharon
    Sawhney, Aanchal
    Khandait, Harshwardhan
    Meda, Amit
    Gupta, Vasu
    Jain, Rohit
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2023, 35 (01)
  • [29] The Reversal of Bleeding Caused by New Oral Anticoagulants (NOACs): A Systematic Review and Meta-Analysis
    Udayachalerm, Sariya
    Rattanasiri, Sasivimol
    Angkananard, Teeranan
    Attia, John
    Sansanayudh, Nakarin
    Thakkinstian, Ammarin
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 : 117S - 126S
  • [30] Old and new anticoagulants - Antidotes and measures for acute hemorrhaging and urgent interventions
    Lance, M.
    Stessel, B.
    Hamulyak, K.
    Marcus, M. A.
    ANAESTHESIST, 2010, 59 (01): : 62 - 68